117 related articles for article (PubMed ID: 27277143)
1. SIRT3 participates in glucose metabolism interruption and apoptosis induced by BH3 mimetic S1 in ovarian cancer cells.
Xiang XY; Kang JS; Yang XC; Su J; Wu Y; Yan XY; Xue YN; Xu Y; Liu YH; Yu CY; Zhang ZC; Sun LK
Int J Oncol; 2016 Aug; 49(2):773-84. PubMed ID: 27277143
[TBL] [Abstract][Full Text] [Related]
2. SIRT3 aggravates metformin-induced energy stress and apoptosis in ovarian cancer cells.
Wu Y; Gao WN; Xue YN; Zhang LC; Zhang JJ; Lu SY; Yan XY; Yu HM; Su J; Sun LK
Exp Cell Res; 2018 Jun; 367(2):137-149. PubMed ID: 29580688
[TBL] [Abstract][Full Text] [Related]
3. Bcl2 inhibitor ABT737 reverses the Warburg effect via the Sirt3-HIF1α axis to promote oxidative stress-induced apoptosis in ovarian cancer cells.
Dong D; Dong Y; Fu J; Lu S; Yuan C; Xia M; Sun L
Life Sci; 2020 Aug; 255():117846. PubMed ID: 32470451
[TBL] [Abstract][Full Text] [Related]
4. ABT737 enhances ovarian cancer cells sensitivity to cisplatin through regulation of mitochondrial fission via Sirt3 activation.
Hou L; Wang R; Wei H; Li S; Liu L; Lu X; Yu H; Liu Z
Life Sci; 2019 Sep; 232():116561. PubMed ID: 31247208
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of JNK3 promotes apoptosis induced by BH3 mimetic S1 in chemoresistant human ovarian cancer cells.
Yang X; Xiang X; Xia M; Su J; Wu Y; Shen L; Xu Y; Sun L
Anat Rec (Hoboken); 2015 Feb; 298(2):386-95. PubMed ID: 25044439
[TBL] [Abstract][Full Text] [Related]
6. The BH3 mimetic S1 induces endoplasmic reticulum stress-associated apoptosis in cisplatin-resistant human ovarian cancer cells although it activates autophagy.
Liu N; Xu Y; Sun JT; Su J; Xiang XY; Yi HW; Zhang ZC; Sun LK
Oncol Rep; 2013 Dec; 30(6):2677-84. PubMed ID: 24100381
[TBL] [Abstract][Full Text] [Related]
7. Identification of Sirtuin 3, a mitochondrial protein deacetylase, as a new contributor to tamoxifen resistance in breast cancer cells.
Zhang L; Ren X; Cheng Y; Huber-Keener K; Liu X; Zhang Y; Yuan YS; Yang JW; Liu CG; Yang JM
Biochem Pharmacol; 2013 Sep; 86(6):726-33. PubMed ID: 23856293
[TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis.
Saulle E; Petronelli A; Pasquini L; Petrucci E; Mariani G; Biffoni M; Ferretti G; Scambia G; Benedetti-Panici P; Cognetti F; Humphreys R; Peschle C; Testa U
Apoptosis; 2007 Apr; 12(4):635-55. PubMed ID: 17252198
[TBL] [Abstract][Full Text] [Related]
9. A novel BH3 mimetic S1 potently induces Bax/Bak-dependent apoptosis by targeting both Bcl-2 and Mcl-1.
Zhang Z; Song T; Zhang T; Gao J; Wu G; An L; Du G
Int J Cancer; 2011 Apr; 128(7):1724-35. PubMed ID: 20503275
[TBL] [Abstract][Full Text] [Related]
10. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
Simonin K; N'Diaye M; Lheureux S; Loussouarn C; Dutoit S; Briand M; Giffard F; Brotin E; Blanc-Fournier C; Poulain L
Apoptosis; 2013 Apr; 18(4):492-508. PubMed ID: 23344663
[TBL] [Abstract][Full Text] [Related]
11. Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2.
Li J; Jiang K; Zhao F
Oncol Rep; 2015 Jun; 33(6):2829-36. PubMed ID: 25845681
[TBL] [Abstract][Full Text] [Related]
12. Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells.
Yang Y; Cao Y; Chen L; Liu F; Qi Z; Cheng X; Wang Z
Cancer Med; 2018 Sep; 7(9):4610-4618. PubMed ID: 30094960
[TBL] [Abstract][Full Text] [Related]
13. Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer.
Shin JA; Kim LH; Lee SJ; Jeong JH; Jung JY; Lee HN; Hong IS; Cho SD
Oncotarget; 2015 Nov; 6(34):35667-83. PubMed ID: 26447615
[TBL] [Abstract][Full Text] [Related]
14. BIRO1, a cell-permeable BH3 peptide, promotes mitochondrial fragmentation and death of retinoblastoma cells.
Allaman-Pillet N; Oberson A; Schorderet DF
Mol Cancer Res; 2015 Jan; 13(1):86-97. PubMed ID: 25143432
[TBL] [Abstract][Full Text] [Related]
15. A Novel Bioavailable BH3 Mimetic Efficiently Inhibits Colon Cancer via Cascade Effects of Mitochondria.
Wang X; Zhang C; Yan X; Lan B; Wang J; Wei C; Cao X; Wang R; Yao J; Zhou T; Zhou M; Liu Q; Jiang B; Jiang P; Kesari S; Lin X; Guo F
Clin Cancer Res; 2016 Mar; 22(6):1445-58. PubMed ID: 26515494
[TBL] [Abstract][Full Text] [Related]
16. Sirt3 attenuates hydrogen peroxide-induced oxidative stress through the preservation of mitochondrial function in HT22 cells.
Dai SH; Chen T; Wang YH; Zhu J; Luo P; Rao W; Yang YF; Fei Z; Jiang XF
Int J Mol Med; 2014 Oct; 34(4):1159-68. PubMed ID: 25090966
[TBL] [Abstract][Full Text] [Related]
17. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
Witham J; Valenti MR; De-Haven-Brandon AK; Vidot S; Eccles SA; Kaye SB; Richardson A
Clin Cancer Res; 2007 Dec; 13(23):7191-8. PubMed ID: 18056200
[TBL] [Abstract][Full Text] [Related]
18. Anticancer and chemosensitizing effects of 2,3-DCPE in ovarian carcinoma cell lines: link with ERK activation and modulation of p21WAF1/CIP1, Bcl-2 and Bcl-xL expression.
Villedieu M; Briand M; Duval M; Héron JF; Gauduchon P; Poulain L
Gynecol Oncol; 2007 May; 105(2):373-84. PubMed ID: 17276501
[TBL] [Abstract][Full Text] [Related]
19. Caspase-mediated cleavage of Beclin1 inhibits autophagy and promotes apoptosis induced by S1 in human ovarian cancer SKOV3 cells.
Li X; Su J; Xia M; Li H; Xu Y; Ma C; Ma L; Kang J; Yu H; Zhang Z; Sun L
Apoptosis; 2016 Feb; 21(2):225-38. PubMed ID: 26573276
[TBL] [Abstract][Full Text] [Related]
20. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.
Lee S; Choi EJ; Jin C; Kim DH
Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
